Ocugen Eulerpool Uudised

Ocugen aktsia uudised

Ocugen jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Ocugen uudised paneme siia kokku.

• 18. juuni ·

  SeekingAlpha
  Ocugen: Three Potential Gene-Therapy Filings By 2028
• 17. juuni ·

  Yahoo
  FDA clears Ocugen’s IND amendment for trial of Stargardt disease treatment
• 16. juuni ·

  Yahoo
  Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease
• 11. juuni ·

  Yahoo
  Ocugen To Present at BIO International Convention 2025
• 5. juuni ·

  Yahoo
  Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
• 27. mai ·

  Yahoo
  Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
• 9. mai ·

  Yahoo
  Ocugen: Q1 Earnings Snapshot
• 9. mai ·

  Yahoo
  Ocugen Provides Business Update with First Quarter 2025 Financial Results
• 9. mai ·

  SeekingAlpha
  Ocugen, Inc. (OCGN) Q1 2025 Earnings Call Transcript
• 2. mai ·

  Yahoo
  Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results